Published in J Clin Pathol on May 01, 2001
Bench to bedside and back again: molecular mechanisms of alpha-catenin function and roles in tumorigenesis. Semin Cancer Biol (2007) 1.76
Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation. J Clin Pathol (2006) 1.31
Altered expression of desmocollin 3, desmoglein 3, and beta-catenin in oral squamous cell carcinoma: correlation with lymph node metastasis and cell proliferation. Virchows Arch (2007) 1.26
Nuclear β-catenin accumulation is associated with increased expression of Nanog protein and predicts poor prognosis of non-small cell lung cancer. J Transl Med (2013) 1.09
IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer. J Exp Clin Cancer Res (2013) 1.07
Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1. PLoS One (2009) 1.04
E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPases. Oncogene (2010) 1.02
Plakoglobin is required for maintenance of the cortical actin skeleton in early Xenopus embryos and for cdc42-mediated wound healing. J Cell Biol (2002) 1.01
Nuclear localization of beta-catenin involved in precancerous change in oral leukoplakia. Mol Cancer (2007) 0.96
Relationship between expression of E-cadherin-catenin complex and clinicopathologic characteristics of pancreatic cancer. World J Gastroenterol (2003) 0.94
miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis. BMC Cancer (2014) 0.94
Mutations of the APC, beta-catenin, and axin 1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma. J Cancer Res Clin Oncol (2005) 0.90
Combined immunohistochemistry of beta-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer. BMC Cancer (2006) 0.89
DLC1 interaction with α-catenin stabilizes adherens junctions and enhances DLC1 antioncogenic activity. Mol Cell Biol (2012) 0.88
Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis. PLoS One (2014) 0.86
Global gene expression in granulosa cells of growing, plateau and atretic dominant follicles in cattle. Reprod Biol Endocrinol (2015) 0.83
Biological and prognostic role of acid cysteine proteinase inhibitor (ACPI, cystatin A) in non-small-cell lung cancer. J Clin Pathol (2006) 0.79
A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression. Virchows Arch (2005) 0.79
Microsatellite analysis of the adenomatous polyposis coli (APC) gene and immunoexpression of beta catenin in nephroblastoma: a study including 83 cases treated with preoperative chemotherapy. J Clin Pathol (2005) 0.78
Adhesion molecules affected by treatment of lung cancer cells with epidermal growth factor. Lung (2011) 0.78
Clinical significance of aberrant Wnt7a promoter methylation in human non-small cell lung cancer in Koreans. J Korean Med Sci (2015) 0.78
Signal transduction growth factors: the effective governance of transcription and cellular adhesion in cancer invasion. Oncotarget (2017) 0.75
The expression of plakoglobin is a potential prognostic biomarker for patients with surgically resected lung adenocarcinoma. Oncotarget (2016) 0.75
Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract (1998) 2.63
E-cadherin mediated adhesion system in cancer cells. Cancer (1996) 1.94
The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer. Mol Cell Biol Res Commun (1999) 1.88
Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation. Am J Pathol (1999) 1.87
The role of beta-catenin in cell adhesion, signal transduction, and cancer. Curr Opin Oncol (1998) 1.46
Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J Pathol (1997) 1.43
Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors. Cancer Res (1996) 1.41
Immunohistochemical detection of alpha-catenin expression in human cancers. Am J Pathol (1994) 1.40
Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions. Oncology (1997) 1.37
Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br J Cancer (1997) 1.25
The cadherin-catenin system: implications for growth and differentiation of endocrine tissues. Endocr Rev (1999) 1.24
Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer. Am J Respir Crit Care Med (1998) 1.23
Predictive value of nuclear beta-catenin expression for the occurrence of distant metastases in rectal cancer. Dis Colon Rectum (1998) 1.20
Expression of beta-catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and alpha-catenin. Histopathology (1996) 1.15
The expression of p120ctn protein in breast cancer is independent of alpha- and beta-catenin and E-cadherin. Am J Pathol (1998) 1.12
Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. J Pathol (1998) 1.10
Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer. Br J Cancer (1999) 1.07
Cadherin and catenin biology represent a global mechanism for epithelial cancer progression. Mol Pathol (1997) 1.06
Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer. J Clin Oncol (1998) 1.05
Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small-cell lung cancer. J Clin Oncol (1998) 1.00
The expression of beta-catenin in non-small-cell lung cancer: a clinicopathological study. J Clin Pathol (1998) 0.99
Cytoplasmic beta-catenin in esophageal cancers. Int J Cancer (1999) 0.99
Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study. Hepatology (1998) 0.97
Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer. J Urol (1998) 0.93
Nuclear beta catenin expression is related to unfavourable outcome in oropharyngeal and hypopharyngeal squamous cell carcinoma. J Clin Pathol (2001) 0.92
Cadherin and catenin expression in normal human bronchial epithelium and non-small cell lung cancer. Lung Cancer (1999) 0.90
Cytoplasmic accumulation of alpha-catenin is associated with aggressive features in laryngeal squamous-cell carcinoma. Int J Cancer (1998) 0.90
Level of alpha-catenin expression in colorectal cancer correlates with invasiveness, metastatic potential, and survival. J Surg Oncol (1998) 0.88
Pancreatic carcinoma: correlation between E-cadherin and alpha-catenin expression status and liver metastasis. Cancer (1998) 0.88
Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma. Hum Pathol (2000) 0.86
p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma. J Clin Oncol (1997) 0.81
Imaging lung cancer. Semin Oncol (1999) 0.79
A comparison of diets with and without oats in adults with celiac disease. N Engl J Med (1995) 4.14
Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol (1997) 3.09
Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone in the rat. J Natl Cancer Inst (1997) 2.38
Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer (1992) 1.96
Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol (2000) 1.93
Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma. Int J Cancer (1997) 1.82
High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res (2000) 1.77
Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res (1998) 1.59
Nutritional status of newly diagnosed celiac disease patients before and after the institution of a celiac disease diet--association with the grade of mucosal villous atrophy. Am J Clin Nutr (1998) 1.49
Comparative liver toxicity of various erythromycin derivatives in animals. J Antimicrob Chemother (1988) 1.41
Osteoporosis in adult patients with celiac disease. Bone (1999) 1.41
Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer (1994) 1.40
DNA profiling of primary serous ovarian and fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation-dependent probe amplification. J Pathol (2007) 1.40
Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis (2001) 1.37
Enzyme replacement therapy in a mouse model of aspartylglycosaminuria. FASEB J (2000) 1.24
Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. Br J Cancer (1996) 1.24
Polymorphic catechol-O-methyltransferase gene and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2001) 1.23
Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Br J Cancer (1999) 1.21
Lack of cellular and humoral immunological responses to oats in adults with coeliac disease. Gut (2000) 1.20
High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer. Eur J Cancer (2001) 1.18
Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma. J Clin Oncol (1998) 1.15
Mast cells in breast cancer. Anticancer Res (1993) 1.13
Hormone receptors as prognostic factors in female breast cancer. Ann Med (1991) 1.12
Bone recovery after a gluten-free diet: a 5-year follow-up study. Bone (1999) 1.11
Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer. Prostate (1999) 1.11
Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer. Br J Cancer (2000) 1.09
Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol Biomarkers Prev (2001) 1.08
The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer. J Cancer Res Clin Oncol (1996) 1.08
p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women. Mol Pathol (2000) 1.07
Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer. Br J Cancer (1999) 1.07
Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation. J Clin Pathol (2001) 1.06
Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer. J Clin Oncol (1998) 1.05
Dose and time dependency of inflammatory responses in the mouse lung to urban air coarse, fine, and ultrafine particles from six European cities. Inhal Toxicol (2007) 1.04
Expression of hyaluronan in benign and malignant breast lesions. Int J Cancer (1997) 1.04
Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables. Cancer Genet Cytogenet (2000) 1.03
Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma. Br J Cancer (2003) 1.02
Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. J Pathol (1995) 1.02
Steroid metabolism gene CYP17 polymorphism and the development of breast cancer. Cancer Epidemiol Biomarkers Prev (2000) 1.00
Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer. Anticancer Res (2001) 1.00
Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. Scand J Gastroenterol (1998) 0.99
Reduced expression of alpha catenin is associated with poor prognosis in colorectal carcinoma. J Clin Pathol (1999) 0.99
Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma. Am J Pathol (2000) 0.98
p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer. Br J Cancer (1999) 0.97
Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Br J Cancer (1999) 0.97
Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival. Eur J Cancer (1995) 0.96
Hypothyroidism after radiotherapy for laryngeal cancer. Radiother Oncol (2000) 0.96
p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis. Br J Cancer (1999) 0.95
Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains. Cancer Res (2000) 0.94
Expression of hyaluronan in normal and dysplastic bronchial epithelium and in squamous cell carcinoma of the lung. Int J Cancer (1998) 0.93
Decline after immobilisation and recovery after remobilisation of synovial fluid IL1, TIMP, and chondroitin sulphate levels in young beagle dogs. Ann Rheum Dis (2001) 0.93
Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma. Int J Cancer (2001) 0.92
Mesenchymoma of the chest wall in children. Ann Thorac Surg (1991) 0.92
Nuclear beta catenin expression is related to unfavourable outcome in oropharyngeal and hypopharyngeal squamous cell carcinoma. J Clin Pathol (2001) 0.92
Churg-Strauss syndrome manifested by appendicitis, cholecystitis and superficial micronodular liver lesions--an unusual clinicopathological presentation. J Clin Pathol (2010) 0.91
Irregular expression of hyaluronan and its CD44 receptor is associated with metastatic phenotype in laryngeal squamous cell carcinoma. Virchows Arch (1999) 0.91
Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease. Neurobiol Aging (1988) 0.90
Cytoplasmic accumulation of alpha-catenin is associated with aggressive features in laryngeal squamous-cell carcinoma. Int J Cancer (1998) 0.90
Verrucous carcinoma of the anus containing human papillomavirus type 16 DNA detected by in situ hybridisation: a case report. Genitourin Med (1990) 0.90
Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival. Anticancer Res (1995) 0.89
Sensory irritating potency of some microbial volatile organic compounds (MVOCs) and a mixture of five MVOCs. Arch Environ Health (1999) 0.89
p21(WAF1/CIP1) expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival. Br J Cancer (1999) 0.89
Biodistribution of adenoviral vector to nontarget tissues after local in vivo gene transfer to arterial wall using intravascular and periadventitial gene delivery methods. FASEB J (2000) 0.89
Inflammatory responses in mice after intratracheal instillation of spores of Streptomyces californicus isolated from indoor air of a moldy building. Toxicol Appl Pharmacol (2001) 0.89
Oxidative/nitrosative stress and peroxiredoxin 2 are associated with grade and prognosis of human renal carcinoma. APMIS (2006) 0.89
Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancer. Eur Urol (2001) 0.88
Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2alpha in cutaneous melanoma. Br J Cancer (2000) 0.87
Tumor size, nuclear morphometry, mitotic indices as prognostic factors in axillary-lymph-node-positive breast cancer. Eur Surg Res (1992) 0.87
Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer. Histopathology (2001) 0.87
Versican expression in pharyngeal squamous cell carcinoma: an immunohistochemical study. J Clin Pathol (2004) 0.87
Evaluation of p21WAF1/CIP1 and cyclin D1 expression in the progression of superficial bladder cancer. Finbladder Group. Urol Res (2000) 0.86
Correlation of MIB-1 antigen expression with transcription factors Skn-1, Oct-1, AP-2, and HPV type in cervical intraepithelial neoplasia. J Pathol (1997) 0.86
Low claudin expression is associated with high Gleason grade in prostate adenocarcinoma. Oncol Rep (2008) 0.86
Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma. Hum Pathol (2000) 0.86
Standardized mitotic counts in breast cancer. Evaluation of the method. Pathol Res Pract (1996) 0.85
Expression of inducible nitric oxide synthase in colorectal cancer and its association with prognosis. Scand J Gastroenterol (2000) 0.85
The prognostic value of inducible nitric oxide synthase in local prostate cancer. BJU Int (2000) 0.85
Prognostic value of cathepsin-D expression in female breast cancer. Anticancer Res (1995) 0.85
K-ras and p53 mutations and overexpressions as prognostic factors in female rectal carcinoma. Anticancer Res (1999) 0.84
Human carotid arteries: correlation of intravascular US with angiographic and histopathologic findings. Radiology (1998) 0.84
Markers of cartilage and synovial metabolism in joint fluid and serum of patients with chondromalacia of the patella. Osteoarthritis Cartilage (1998) 0.84
Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up. J Pathol (1998) 0.84
Prognostic factors in axillary lymph node-negative (pN-) breast carcinomas. Eur J Cancer (1991) 0.84
The influence of dichloromethylene bisphosphonate on the healing of a long bone fracture, composition of bone mineral and histology of bone in the rat. Pharmacol Toxicol (1994) 0.83
Mitotic indexes as prognostic predictors in female breast cancer. J Cancer Res Clin Oncol (1992) 0.83
Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women. Br J Cancer (1999) 0.83
Effects of 50 Hz magnetic fields on UV-induced skin tumourigenesis in ODC-transgenic and non-transgenic mice. Int J Radiat Biol (1998) 0.83
DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer. Int J Cancer (1992) 0.83
Xanthogranuloma juvenile--a rare cause of orbital swelling in adulthood. Ophthalmologica (1992) 0.83
Elimination and toxicity of perfluorooctanoic acid during subchronic administration in the Wistar rat. Pharmacol Toxicol (1987) 0.83